PT Indofarma Tbk (ISX:INAF) FCF Margin % : -108.74% (As of Sep. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. PT Indofarma Tbk's Free Cash Flow for the three months ended in Sep. 2023 was Rp-88,884 Mil. PT Indofarma Tbk's Revenue for the three months ended in Sep. 2023 was Rp81,737 Mil. Therefore, PT Indofarma Tbk's FCF Margin % for the quarter that ended in Sep. 2023 was -108.74%.

As of today, PT Indofarma Tbk's current FCF Yield % is -28.89%.

The historical rank and industry rank for PT Indofarma Tbk's FCF Margin % or its related term are showing as below:

ISX:INAF' s FCF Margin % Range Over the Past 10 Years
Min: -36.6 Med: 1.63 Max: 6.86
Current: -36.6

During the past 13 years, the highest FCF Margin % of PT Indofarma Tbk was 6.86%. The lowest was -36.60%. And the median was 1.63%.

ISX:INAF's FCF Margin % is ranked worse than
83.25% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 0.08 vs ISX:INAF: -36.60

PT Indofarma Tbk FCF Margin % Historical Data

The historical data trend for PT Indofarma Tbk's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk FCF Margin % Chart

PT Indofarma Tbk Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-7.35

1.34

1.91

2.46

-11.02

PT Indofarma Tbk Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Margin %	Get a 7-Day Free Trial															3.01	-24.18	-34.43	-23.43	-108.74

Competitive Comparison of PT Indofarma Tbk's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Indofarma Tbk's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's FCF Margin % distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's FCF Margin % falls into.

PT Indofarma Tbk FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

PT Indofarma Tbk's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-126049.619	/	1144108.231
	=	-11.02 %

PT Indofarma Tbk's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-88884.193	/	81736.853
	=	-108.74 %

PT Indofarma Tbk FCF Margin % Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website

http://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines